Innocan Pharma’s Case Report Accepted to the 25M Readers of Frontiers Veterinary Scientific Journal

Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – April 11, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”), is pleased to report the “accepted…

The Future Markets Research Releases Market Commentary on Innocan Pharma, an up-and-coming Leader in CBD Veterinary Solutions

Article content LONDON — PESG Research, a research group under the Future Markets Research Tank (FMRT), in proud to release market commentary on Innocan Pharma, an up-and-coming leader in the…

With recent expansion into veterinary field, Innocan Pharma is primed for major growth

Innocan Pharma (CSE:INNO) As investors, we always need to be prudent with our research into potential investments. There are tens of thousands of stocks across dozens of exchanges, all with…

With recent expansion into veterinary field, Innocan Pharma (INNO Stock) is primed for major growth

Innocan Pharma (CSE:INNO) As investors, we always need to be prudent with our research into potential investments. There are tens of thousands of stocks across dozens of exchanges, all with…

Innocan Pharma to Expand its LPT Platform to the Veterinary Field

Herzliya, Israel and Calgary, Alberta – (Newsfile Corp. – January 13, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) is pleased , a…